BFM
AEON icon

Boothbay Fund Management’s AEON Biopharma AEON Stock Holding History

Boothbay Fund Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-759
Closed -$29.5K – 1369
2024
Q4 		$29.5K Sell
759
-6
-0.8% -$349 ﹤0.01% 1404
2024
Q3 		$57.8K Hold
765
– – ﹤0.01% 1501
2024
Q2 		$57.8K Hold
765
– – ﹤0.01% 1404
2024
Q1 		$639K Hold
765
– – 0.01% 917
2023
Q4 		$396K Hold
765
– – 0.01% 1082
2023
Q3 		$308K Buy
+765
New +$350K 0.01% 1236
2023
Q2 		– Sell
-983
Closed -$718K – 1754
2023
Q1 		$718K Sell
983
-1,693
-63% -$1.23M 0.01% 1131
2022
Q4 		$1.94M Buy
2,676
+2,364
+758% +$1.69M 0.04% 610
2022
Q3 		$221K Buy
+312
New +$221K 0.01% 1753

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Boothbay Fund Management's AEON Position: Q1 2025 in Review

Boothbay Fund Management sold out of AEON Biopharma (AEON) in Q1 2025, closing a stake of 759 shares — an estimated $29.5K sold.

Boothbay Fund Management first reported a position in AEON in Q3 2022 and held it in 9 quarters. The position peaked at $1.94M in Q4 2022. 16 funds tracked by Wall St. Rank hold AEON as of Q1 2025.

  • Boothbay Fund Management reported no remaining AEON Biopharma position as of Q1 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 759 AEON Biopharma shares in Q1 2025, an estimated $29.5K.
  • Boothbay Fund Management first reported a position in AEON Biopharma in Q3 2022 and held it in 9 quarters.
  • Boothbay Fund Management's AEON Biopharma position peaked at $1.94M in Q4 2022.
  • 16 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2025.

Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.